Grauer & Weil (India) Ltd Valuation Shifts Signal Heightened Price Risk

1 hour ago
share
Share Via
Grauer & Weil (India) Ltd has seen a marked shift in its valuation parameters, moving from expensive to very expensive territory, as reflected in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change, coupled with a recent downgrade to a Strong Sell rating by MarketsMojo, raises important questions about the stock’s price attractiveness relative to its historical averages and peer group within the commodity chemicals sector.
Grauer & Weil (India) Ltd Valuation Shifts Signal Heightened Price Risk

Valuation Metrics Reflect Elevated Price Levels

As of 11 May 2026, Grauer & Weil’s P/E ratio stands at 22.71, a level that places it firmly in the very expensive category compared to its own historical valuation and many peers. The price-to-book value ratio has also increased to 3.19, signalling that investors are paying over three times the company’s net asset value. These valuation multiples have deteriorated from previous levels, indicating a less favourable entry point for prospective investors.

Other valuation indicators such as the enterprise value to EBIT (EV/EBIT) at 19.48 and enterprise value to EBITDA (EV/EBITDA) at 16.60 further corroborate the elevated pricing. These multiples are high relative to typical benchmarks for commodity chemical companies, suggesting that the market is pricing in strong future earnings growth or operational improvements that may not yet be fully realised.

Peer Comparison Highlights Relative Overvaluation

When compared with key peers in the commodity chemicals sector, Grauer & Weil’s valuation remains on the lower end of the very expensive spectrum but still signals caution. For instance, Navin Fluorine International trades at a P/E of 53.99 and an EV/EBITDA of 33.35, while Himadri Speciality Chemical’s P/E is 42.62 with an EV/EBITDA of 33.19. Deepak Nitrite and Sumitomo Chemical also exhibit very expensive valuations with P/E ratios of 47.17 and 44.61 respectively.

In contrast, Atul Ltd, classified as expensive rather than very expensive, has a P/E of 30.84 and EV/EBITDA of 18.77, while Aarti Industries is rated fair with a P/E of 42.75 but a lower EV/EBITDA of 18.86. This context suggests that while Grauer & Weil is not the most overvalued in its sector, its valuation premium is significant enough to warrant caution, especially given its small-cap status and the inherent volatility that accompanies such stocks.

Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!

  • - Highest rated stock selection
  • - Multi-parameter screening cleared
  • - Large Cap quality pick

View Our Top 1% Pick →

Financial Performance and Returns Contextualise Valuation Concerns

Grauer & Weil’s return on capital employed (ROCE) is a robust 28.70%, and return on equity (ROE) stands at 15.14%, indicating efficient utilisation of capital and reasonable profitability. However, the dividend yield remains modest at 0.71%, which may not be sufficiently attractive for income-focused investors.

Examining stock returns relative to the Sensex reveals a mixed picture. Over the past week and month, Grauer & Weil has marginally outperformed the benchmark, with returns of 0.59% and 6.38% respectively, compared to Sensex’s 0.54% and -0.30%. Year-to-date, the stock has declined by 5.91%, though this is less severe than the Sensex’s 9.26% fall. Over longer horizons, the stock has delivered impressive gains, with a 5-year return of 164.98% and a 10-year return of 380.41%, significantly outpacing the Sensex’s 57.15% and 206.51% respectively.

Market Capitalisation and Rating Update

Grauer & Weil is classified as a small-cap stock, which typically entails higher volatility and risk compared to large-cap peers. Reflecting these risks and valuation concerns, MarketsMOJO downgraded the company’s mojo grade from Sell to Strong Sell on 21 April 2026, with a current mojo score of 27.0. This downgrade signals a deteriorating outlook and advises caution for investors considering new positions at current price levels.

Price Movement and Trading Range

The stock closed at ₹70.02 on 11 May 2026, up 0.42% from the previous close of ₹69.73. The intraday trading range was ₹69.15 to ₹70.89, indicating relatively tight price movement. The 52-week high remains at ₹111.45, while the 52-week low is ₹49.70, showing a wide trading band and potential for volatility depending on market sentiment and sector developments.

Why settle for Grauer & Weil (India) Ltd? SwitchER evaluates this Commodity Chemicals small-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Implications for Investors

The shift in valuation parameters for Grauer & Weil from expensive to very expensive suggests that the stock’s price attractiveness has diminished considerably. While the company’s operational metrics such as ROCE and ROE remain strong, the elevated multiples imply that much of the anticipated growth or profitability is already priced in. This reduces the margin of safety for new investors and increases the risk of price corrections if growth expectations are not met.

Moreover, the downgrade to a Strong Sell rating by MarketsMOJO underscores the caution warranted at current levels. Investors should weigh the stock’s historical outperformance against the current valuation premium and sector dynamics before committing capital. Given the small-cap nature of the company, volatility may be amplified, and liquidity constraints could impact trading.

Conclusion

Grauer & Weil (India) Ltd’s recent valuation changes highlight a significant shift in price attractiveness, with P/E and P/BV ratios now signalling very expensive territory relative to historical norms and peer averages. Despite solid profitability metrics and a respectable dividend yield, the stock’s elevated multiples and recent rating downgrade suggest heightened risk for investors. Careful analysis and consideration of alternative opportunities within the commodity chemicals sector or broader market may be prudent for those seeking better risk-adjusted returns.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News